KJI
- Product code
- KJI
- Device name
- Radioimmunoassay, Kanamycin
- Device class
- Class 2
- 21 CFR
- 21 CFR 862.3520
- Medical specialty
- Clinical Toxicology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (last 3 years)
- 6
Official FDA classification page: KJI
Classification and pathway per current FDA publications. Data from openFDA (CC0).